Kaffes Stent in the Management of Post-surgical Biliary Strictures

Sponsor
Cairo University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03716232
Collaborator
Theodor Bilharz Research Institute (Other), National Hepatology & Tropical Medicine Research Institute (Other)
30
3
2
30
10
0.3

Study Details

Study Description

Brief Summary

Post-surgical biliary strictures are common especially after cholecystectomy. Standard treatment involves the performance of multiple procedures over a 1 year period at least using several plastic stents to achieve permanent dilatation of these strictures.

Metallic stents have the theoretical benefit of absence of need of multiple sessions.

These strictures however are frequently very close to the hilum and thus previously considered a contraindication for insertion of metallic stents for the fear of occlusion of the contralateral ducts. Metallic stent migration is also a frequent problem.

The use of a metallic stent that is short and completely intraductal, in theory, should reduce the risk of stent migration.

This is a randomized controlled trial comparing the efficacy and safety of a short metallic intraductal stent to the conventional treatment which is multiple plastic stents. In cases with a stricture reaching or close to the hilum a technique is used to avoid obstruction of the contralateral ducts which is insertion of a 7 French plastic stent alongside the metallic stent.

Condition or Disease Intervention/Treatment Phase
  • Device: Metallic stent
  • Device: Multiple plastic stents
Phase 3

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Safety and Efficacy of a Short Specially Designed Fully Covered Metallic Stent in the Management of Benign Post-surgical Biliary Strictures: a Randomized-controlled Study
Actual Study Start Date :
Jul 1, 2018
Anticipated Primary Completion Date :
Jul 31, 2020
Anticipated Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Multiple plastic stents

All procedures will be performed under propofol sedation. Strictures will be identified by cholangiography and then dilated by a dilating balloon (diameter 6-10mm). A 10 French plastic stent will be inserted bypassing the level of the stricture. Stent replacement and the addition of further stents will be planned after 3 months from the initial procedure and every 3 months until stricture resolution occurs with a maximum of four procedures. Balloon dilatation with a 6-10 mm balloon will be used in each session before stent insertion.

Device: Multiple plastic stents
Strictures will be identified by cholangiography and then dilated by a dilating balloon (diameter 6-10mm). A 10 French plastic stent will be inserted bypassing the level of the stricture. Stent replacement and the addition of further stents will be planned after 3 months from the initial procedure and every 3 months until stricture resolution occurs with a maximum of four procedures. Balloon dilatation with a 6-10 mm balloon will be used in each session before stent insertion.

Experimental: Metallic stent

All procedures will be performed under propofol sedation. Strictures will be identified by cholangiography and then dilated by a dilating balloon (diameter 6-10mm). A 4-6cm fully covered expandable metallic stent (Kaffes stent, Taewoong medical, Seoul, Korea) will then be deployed at the level of the stricture. In cases close to the hepatic hilum where the deployment of the stent is expected to reach one duct and possibly block another duct, a 7 Fr stent will be inserted prior to deployment of the metallic stent in the contralateral duct.. - Stent will be extracted endoscopically after 6 months.

Device: Metallic stent
All procedures will be performed under propofol sedation. Strictures will be identified by cholangiography and then dilated by a dilating balloon (diameter 6-10mm). A 4-6cm fully covered expandable metallic stent (Kaffes stent, Taewoong medical, Seoul, Korea) will then be deployed at the level of the stricture. In cases close to the hepatic hilum where the deployment of the stent is expected to reach one duct and possibly block another duct, a 7 Fr stent will be inserted prior to deployment of the metallic stent in the contralateral duct.. - Stent will be extracted endoscopically after 6 months.

Outcome Measures

Primary Outcome Measures

  1. Clinical success [6 months after removal of stents]

    Proportion of patients with Absence of clinical or laboratory evidence of recurrence of biliary obstruction

Secondary Outcome Measures

  1. Technical success [At time of procedure]

    Proportion of patients with Successful deployment of stents

  2. Stricture resolution at end of treatment [After 6 months in the metallic stent group and after 12 or 15 months in the multiple plastic stents group]

    Radiological resolution of the stricture at the time of removal of the stents (after insertion of 3 or 4 stents) and after removal of the metallic stent.

  3. Occurrence of complications [up to 6 months after the last procedure]

    occurence of any procedure-related complication

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Confirmed benign postsurgical biliary stricture by presence of all 3 of the following:

Ultrasound imaging or Magnetic resonance cholangiopancreatography (MRCP) showing biliary dilatation, Raised bilirubin and or alkaline phosphatase, History of biliary tree surgery within the previous year

  • Naïve to endoscopic therapy

  • Age > 18 years

Exclusion Criteria:
  • Coagulopathy

  • Inability of patient to adhere to regular follow-up

  • Living-donor liver transplant patients

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kasr Alaini University Hospital Cairo New Cairo Egypt 11771
2 National hepatology and tropical medicine research institute Cairo Egypt 11562
3 Theodor Bilharz Institute Cairo Egypt 11562

Sponsors and Collaborators

  • Cairo University
  • Theodor Bilharz Research Institute
  • National Hepatology & Tropical Medicine Research Institute

Investigators

  • Principal Investigator: hany shehab, FRCP, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hany Shehab, Associate professor, Cairo University
ClinicalTrials.gov Identifier:
NCT03716232
Other Study ID Numbers:
  • HPB01
First Posted:
Oct 23, 2018
Last Update Posted:
Mar 17, 2020
Last Verified:
Mar 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 17, 2020